Impaired dopamine release in Parkinson's disease.

Cramb, Kaitlyn M L; Beccano-Kelly, Dayne; Cragg, Stephanie J; Wade-Martins, Richard

Cramb, Kaitlyn M L; Beccano-Kelly, Dayne; Cragg, Stephanie J; Wade-Martins, Richard.

Afiliación

Cramb KML; Oxford Parkinson's Disease Centre and Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3QU, UK.
Beccano-Kelly D; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.
Cragg SJ; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.
Wade-Martins R; Oxford Parkinson's Disease Centre and Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3QU, UK.

Brain ; 146(8): 3117-3132, 2023 08 01.

Article en En | MEDLINE | ID: mdl-36864664

Asunto(s)

Enfermedades Neurodegenerativas; Enfermedad de Parkinson; Humanos; Dopamina/metabolismo; Enfermedades Neurodegenerativas/metabolismo; Neuronas Dopaminérgicas/metabolismo

Palabras clave

Parkinson's disease; dopamine release; neurodegeneration

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Enfermedades Neurodegenerativas Límite: Humans Idioma: En Revista: Brain Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google